Showing results (251-260 of 45,155) with videos related to
Sort By:
Pageof 4,516
Cancer Research|June 19, 2001
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progressionA Akalin, L W Elmore, H L Forsythe, et al.Cancer Research|June 19, 2001
Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cellsR Singal, J van Wert, M BashambuCancer Research|June 19, 2001
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2M Cuello, S A Ettenberg, A S Clark, et al.Cancer Research|August 17, 2001
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancerA Rökman, T Ikonen, N Mononen, et al.Cancer Research|August 17, 2001
Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instabilityY Mori, J Yin, A Rashid, et al.Cancer Research|August 17, 2001
Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell linesC Bonnesen, I M Eggleston, J D HayesCancer Research|August 17, 2001
Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanomaA G Niethammer, R Xiang, J M Ruehlmann, et al.Cancer Research|August 17, 2001
Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunityM Odaka, D H Sterman, R Wiewrodt, et al.Cancer Research|August 17, 2001
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR)T Nickerson, F Chang, D Lorimer, et al.Cancer Research|August 17, 2001
An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanismX Hu, W E Janssen, L C Moscinski, et al.Pageof 4,516